Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial

Saved in:
Bibliographic Details
Published inACC current journal review Vol. 13; no. 2; p. 42
Main Authors Tcheng, J.E., Kandzari, D.E., Grines, C.L.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.02.2004
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:1062-1458
DOI:10.1016/j.accreview.2003.12.048